Use of SAA1B/B homozygote in the prognosis and diagnosis of liver cirrhosis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9708663
SERIAL NO

14364240

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is uses of SAA1β/β(1.5/1.5) homozygote in prognosis and/diagnosis of liver cirrhosis, and in preparation of a reagent for liver cirrhosis prognosis and/or liver cirrhosis diagnosis. Recognition of liver cirrhosis susceptible populations can be achieved by detection of human SAA1β/β homozygote and non-SAA1β/β homozygote through real-time fluorescence quantitative allele specific PCR.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DIASYS DIAGNOSTIC SYSTEMS (SHANGHAI) CO LTD201318 BUILDING 16 MODERN BUSINESS PARK SHANGHAI INTERNATIONAL MEDICAL PARK LANE 588 TIANXIONG ROAD PUDONG NEW AREA SHANGHAI SHANGHAI CITY SHANGHAI CITY 201318

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Qian, Zhenbin Shanghai, CN 1 0
Wang, Rongfang Shanghai, CN 5 76
Wu, Jun Shanghai, CN 507 5138
Zhang, Yan Shanghai, CN 881 7426

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 18, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 18, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00